Statistics for Laboratorios Farmaceuticos Rovi SA (id:4678 ROVI)
Valuation metrics
Market cap
3.14B
Enterprise value
3.24B
Trailing P/E (ttm)
19.31
Forward P/E
22.66
PEG ratio
22.66
Price/Sales (ttm)
3.93
Price/Book (mrq)
5.97
Enterprise Value/Revenue
4.05
Enterprise Value/EBITDA
13.84
Overview
Shares outstanding
51.15M
Float
18.61M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
68.95K
Average volume (90 days)
Price summary
52-Week low
59.05
52-Week high
94.80
52-Week change
3.24%
Beta
3.00
50-Day moving average
68.32
200-Day moving average
78.21
Dividends and splits
Forward annual dividend rate
4.41
Forward annual dividend yield
5.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
3.00
Payout ratio
3.00
Dividend date
Ex-dividend date
July 8, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
June 30, 2024
Profitability
Profit margin
20.64%
Operating margin
38.28%
Operational effectiveness
Return on assets
15.55%
Return on equity
29.65%
Income statement
Revenue (ttm)
14.97
Revenue per share (ttm)
14.97
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
492.28M
EBITDA
217.77M
Net income to common (ttm)
165.00M
Diluted EPS (ttm)
3.18
Quarterly earnings growth (yoy)
32.50%
Balance sheet
Total cash (mrq)
17.55M
Total cash per share (mrq)
3.00
Total debt (mrq)
128.28M
Total Debt/Equity (mrq)
22.98
Current ratio (mrq)
250.00%
Book value per share (mrq)
10.28
Cash flow
Cash flow statement
126.18M
Levered free cash flow (LFCF)
48.54M